A label-free aptamer-based cytosensor for specific cervical cancer HeLa cell recognition through a g-C3N4-AgI/ITO photoelectrode

Utilising the Nanozymatic Activity of Copper-Functionalised Mesoporous C3 N5 for Sensing Biomolecules

Designing unique nanomaterials for the selective sensing of biomolecules is of significant interest in the field of nanobiotechnology. In this work, we demonstrated the synthesis of ordered Cu nanoparticle-functionalised mesoporous C3 N5 that has unique peroxidase-like nanozymatic activity for the ultrasensitive and selective detection of glucose and glutathione. A nano hard-templating technique together with the in-situ polymerisation and self-assembly of Cu and high N-containing CN precursor was adopted to introduce mesoporosity as well as high N and Cu content in mesoporous C3 N5 . Due to the ordered structure and highly dispersed Cu in the mesoporous C3 N5 , a large enhancement of the peroxidase mimetic activity in the oxidation of a redox dye in the presence of hydrogen peroxide could be obtained. Additionally, the optimised Cu-functionalised mesoporous C3 N5 exhibited excellent sensitivity to glutathione with a low detection limit of 2.0 ppm. The strong peroxidase activity of the Cu-functionalised mesoporous C3 N5 was also effectively used for the sensing of glucose with a detection limit of 0.4 mM through glucose oxidation with glucose oxidase. This unique Cu-functionalised mesoporous C3 N5 has the potential for detecting various molecules in the environment as well as for next-generation glucose and glutathione diagnostic devices.

Silver Halide-Based Nanomaterials in Biomedical Applications and Biosensing Diagnostics

In recent years, silver halide (AgX, X = Cl, Br, I)-based photocatalytic materials have received increasing research attention owing to their excellent visible-light-driven photocatalytic performance for applications in organic pollutant degradation, HER, OER, and biomedical engineering. Ag as a noble metal has a surface plasma effect and can form Schottky junctions with AgX, which significantly promotes electron transport and increases photocatalytic efficiency. Therefore, Ag/AgX can reduce the recombination rate of electrons and holes more than pure AgX, leading to using AgX as a photocatalytic material in biomedical applications. The use of AgX-based materials in photocatalytic fields can be classified into three categories: AgX (Ag/AgX), AgX composites, and supported AgX materials. In this review, we introduce recent developments made in biomedical applications and biosensing diagnostics of AgX (Ag/AgX) photocatalytic materials. In addition, this review also discusses the photocatalytic mechanism and applications of AgX (Ag/AgX) and supported AgX materials.

Smart nanomaterials for cancer diagnosis and treatment

Innovations in nanomedicine has guided the improved outcomes for cancer diagnosis and therapy. However, frequent use of nanomaterials remains challenging due to specific limitations like non-targeted distribution causing low signal-to-noise ratio for diagnostics, complex fabrication, reduced-biocompatibility, decreased photostability, and systemic toxicity of nanomaterials within the body. Thus, better nanomaterial-systems with controlled physicochemical and biological properties, form the need of the hour. In this context, smart nanomaterials serve as promising solution, as they can be activated under specific exogenous or endogenous stimuli such as pH, temperature, enzymes, or a particular biological molecule. The properties of smart nanomaterials make them ideal candidates for various applications like biosensors, controlled drug release, and treatment of various diseases. Recently, smart nanomaterial-based cancer theranostic approaches have been developed, and they are displaying better selectivity and sensitivity with reduced side-effects in comparison to conventional methods. In cancer therapy, the smart nanomaterials-system only activates in response to tumor microenvironment (TME) and remains in deactivated state in normal cells, which further reduces the side-effects and systemic toxicities. Thus, the present review aims to describe the stimulus-based classification of smart nanomaterials, tumor microenvironment-responsive behaviour, and their up-to-date applications in cancer theranostics. Besides, present review addresses the development of various smart nanomaterials and their advantages for diagnosing and treating cancer. Here, we also discuss about the drug targeting and sustained drug release from nanocarriers, and different types of nanomaterials which have been engineered for this intent. Additionally, the present challenges and prospects of nanomaterials in effective cancer diagnosis and therapeutics have been discussed.

Electrochemical Sensors for Detection of Markers on Tumor Cells

In recent years, the increasing incidence and mortality of cancer have inspired the development of accurate and rapid early diagnosis methods in order to successfully cure cancer; however, conventional methods used for detecting tumor cells, including histopathological and immunological methods, often involve complex operation processes, high analytical costs, and high false positive rates, in addition to requiring experienced personnel. With the rapid emergence of sensing techniques, electrochemical cytosensors have attracted wide attention in the field of tumor cell detection because of their advantages, such as their high sensitivity, simple equipment, and low cost. These cytosensors are not only able to differentiate tumor cells from normal cells, but can also allow targeted protein detection of tumor cells. In this review, the research achievements of various electrochemical cytosensors for tumor cell detection reported in the past five years are reviewed, including the structures, detection ranges, and detection limits of the cytosensors. Certain trends and prospects related to the electrochemical cytosensors are also discussed.

Graphene, an Interesting Nanocarbon Allotrope for Biosensing Applications: Advances, Insights, and Prospects

Graphene, a relatively new two-dimensional (2D) nanomaterial, possesses unique structure (e.g. lighter, harder, and more flexible than steel) and tunable physicochemical (e.g. electronical, optical) properties with potentially wide eco-friendly and cost-effective usage in biosensing. Furthermore, graphene-related nanomaterials (e.g. graphene oxide, doped graphene, carbon nanotubes) have inculcated tremendous interest among scientists and industrials for the development of innovative biosensing platforms, such as arrays, sequencers and other nanooptical/biophotonic sensing systems (e.g. FET, FRET, CRET, GERS). Indeed, combinatorial functionalization approaches are constantly improving the overall properties of graphene, such as its sensitivity, stability, specificity, selectivity, and response for potential bioanalytical applications. These include real-time multiplex detection, tracking, qualitative, and quantitative characterization of molecules (i.e. analytes [H₂O₂, urea, nitrite, ATP or NADH]; ions [Hg²⁺, Pb²⁺, or Cu²⁺]; biomolecules (DNA, iRNA, peptides, proteins, vitamins or glucose; disease biomarkers such as genetic alterations in BRCA1, p53) and cells (cancer cells, stem cells, bacteria, or viruses). However, there is still a paucity of comparative reports that critically evaluate the relative toxicity of carbon nanoallotropes in humans. This manuscript comprehensively reviews the biosensing applications of graphene and its derivatives (i.e. GO and rGO). Prospects and challenges are also introduced.

Visible light-activated self-powered photoelectrochemical aptasensor for ultrasensitive chloramphenicol detection based on DFT-proved Z-scheme Ag2CrO4/g-C3N4/graphene oxide

A visible light self-powered photoelectrochemical (PEC) aptasensor based on silver chromate particles, graphitic carbon nitride nanosheets and graphene oxide sheets (Ag₂CrO₄/g-C₃N₄/GO) for the ultrasensitive detection of chloramphenicol (CAP) was reported in this work. g-C₃N₄ was considered to be the fundamental photoelectric material because of its great oxidation ability of photogenerated hole as well as excellent biocompatibility and low toxicity. However, the narrow light absorption range and rapid carrier recombination rate limit the application of pure g-C₃N₄. Herein, Ag₂CrO₄ and GO as photosensitizer were introduced to improve the photoelectric properties of g-C₃N₄. The photocurrent of the developed ternary composite was about 3 times higher than that of pristine g-C₃N₄, which proves it can be used as a suitable photoelectric active material. Moreover, the mechanism of Z-scheme electron transfer path was proved by density functional theory (DFT) calculation. The fabricated PEC aptasensor exhibited high sensitivity toward CAP with a wide liner response of 0.5 pM to 50 nM and a detection limit of 0.29 pM. The specific recognition mechanism and excellent sensing performance indicated this aptasensor could serve as a useful tool for selective and ultrasensitive CAP detection in practical analysis.

Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis

Rapid and accurate monitoring of cancer cells with high sensitivity is essential for a successful cancer treatment. As high-affinity nucleic acid ligands, aptamers can improve the properties of detection methods by conjugating with intracellular or extracellular cancer biomarkers. Despite the advances in the early detection and treatment of cancer cells, lacking effective early detection tools is one of the causes of a high mortality rate. Aptasensors, which are based on the specificity of aptamer-target recognition, with transduction for analytical purposes have received particular attention due to their high sensitivity and selectivity, simple instrumentation, as well as low production cost. In this review, some selective and sensitive methods were summarized based on advanced nanomaterials towards aptasensing of cancer cells, such as blood, breast, cervical, colon, gastric, liver, and lung cancer cells. This review summarizes advances from 2010 to June 2020 in the development of aptasensors for cancer cell detection. Various aptasensing strategies are assessed according to their potential for reaching relevant limits of sensitivity, specificity, and degrees of multiplexing. Furthermore, we address the remaining challenges and opportunities to integrate aptasensing platforms into point-of-care solutions. Finally, the advantages and limitations of aptamer-based aptasensing strategies were reviewed.

Regulation of cell binding and entry by DNA origami mediated spatial distribution of aptamers

Understanding the effects of surface density and distribution of ligands on their recognition and binding is critical for the regulation of cellular behaviors. However, the correlation of spatial distribution of ligands particularly with cell binding and subsequent entry has been rarely explored. Here, we describe the use of DNA origami mediated spatial distribution of aptamers to regulate receptor ligand binding. Aptamers with tunable yet accurate density and orientation are anchored by virtue of the convenience and precision of DNA origami nanoboxes (DONs) to tailor their attachments. Cell assays demonstrate that the binding of DONs depends on both the density and orientation of aptamers, in which two adjacent aptamers exhibit the highest cellular uptake. The spatial distribution dependent uptake is further validated by utilizing two human cancer cell lines expressed with different levels of membrane receptors. Additionally, anticancer doxorubicin loaded DONs show internalization dependent proliferation inhibition of tumor cells. DNA origami mediated spatial distribution of ligands not only provides a unique method to tune cellular behaviors, but also offers new insights for the optimization of targeted drug delivery for cancer treatment.

Aptamer-based approaches for in vitro molecular detection of cancer

Cancer is typically associated with abnormal production of various tumor-specific molecules known as tumor markers. Probing these markers by utilizing efficient approaches could be beneficial for cancer diagnosis. The current widely-used biorecognition probes, antibodies, suffer from some undeniable shortcomings. Fortunately, novel oligonucleotide-based molecular probes named aptamers are being emerged as alternative detection tools with distinctive advantages compared to antibodies. All of the existing strategies in cancer diagnostics, including those of in vitro detection, can potentially implement aptamers as the detecting moiety. Several studies have been performed in the field of in vitro cancer detection over the last decade. In order to direct future studies, it is necessary to comprehensively summarize and review the current status of the field. Most previous studies involve only a few cancer diagnostic strategies. Here, we thoroughly review recent significant advances on the applications of aptamer in various in vitro detection strategies. Furthermore, we will discuss the status of diagnostic aptamers in clinical trials.

An electrochemical signal-on apta-cyto-sensor for quantitation of circulating human MDA-MB-231 breast cancer cells by transduction of electro-deposited non-spherical nanoparticles of gold

A highly simple, sensitive, specific and low-cost electrochemical apta-cyto-sensor for determination of circulating human MDA-MB-231 breast cancer cells was fabricated. Non-spherical nanoparticles of gold were electro-deposited in the presence of ethosuximide as a shape directing and size controlling agent. The nanoparticles had dimensions ranging 50-150 nm, and covered the underlying surface with a roughness factor of 8.03. The Non-spherical nanoparticles were then employed as the apta-cyto-sensor transducer. A 83-mer DNA aptamer that is specific to capturing the cell surface proteins was immobilized on the transducer surface, and binding with the cells was followed using the ferro/ferricyanide redox marker. The aptamer was immobilized within ∼200 min on the transducer surface. The cells were quantified with an equation of regression of ΔIp(μA) = (1.028 ± 0.027) log (C (cell mL^-1)) + (0.2199 ± 0.0944), a sensitivity of 1.028 μA (log (concentration / cell mL^-1))^-1 and a quantitation limit of 2 cell mL^-1, in a concentration range of 5 to 2 × 10⁶ cell mL^-1. The apta-cyto-sensor selectivity was also evaluated toward AsPC-1, Calu-6, HeLa, MCF-7 and melanoma B16/F10 cell lines. The apta-cyto-sensor had a fabrication reproducibility of 4.2%, regeneration capability of 5.1%, a stability of 35 days, and a potential application for the detection of MDA-MB-231 cells in the spiked blood serum samples with a sensitivity of 0.8975 μA (log (concentration / cell mL^-1))^-1 and a quantitation limit of 5 cell mL^-1, in a concentration range of 10 to 1 × 10³ cell mL^-1. The apta-cyto-sensor would be applicable for breast cancer diagnosis at early stage.

Recent Advances in Identifying Biomarkers and High-Affinity Aptamers for Gynecologic Cancers Diagnosis and Therapy

Cancer is the uncontrollable abnormal division of cell growth, caused due to the varied reasons. Cancer can be expressed in any part of the body, and it is one of the death-causing diseases. Human reproductive organs are commonly damaged by cancer. In particular, the women reproductive system is affected by various cancers including ovarian, cervical, endometrial, vaginal, fallopian tube, and vulvar cancers. Identifying these cancers at earlier stages prevents the damage to the organs. Aptamer is the potential probe that can identify these cancers. Aptamer is an artificial antibody selected from the randomized library of molecules and has a high binding affinity to the target biomarker. Targeting cancers in the reproductive organs using aptamers showed an excellent efficiency of detection compared to other probes. Different aptamers have been generated against the gynaecological cancer biomarkers, which include HE4, CA125, VEGF, OCCA (for ovarian cancer), EGFR, FGFR1, K-ras (for endometrial cancer), HPV E-16, HPV E-7, HPV E-6, tyrosine, and kinase (for cervical cancer), which help to identify the cancers in woman reproductive organs. In this overview, the biomarkers for gynecologic cancers and the relevant diagnosing systems generated using the specific aptamers are discussed. Furthermore, the therapeutic applications of aptamer with gynaecological cancers are narrated.

Graphitic carbon nitride-based nanocomposites and their biological applications: a review

Quantum dots (QDs) have extensive application prospects in the fields of optics, magnetism, catalysis, and biomedicine. New carbon-doped QDs are currently being used in these research fields. Graphitic carbon nitride QDs (g-CNs) composed of only carbon and nitrogen have attracted attention because of their unique optical and catalytic properties. g-CNs have numerous electronic properties and can be used as photocatalytic modifiers in a wide range of applications in electrochemistry. Additionally, g-CNs also have biological potential and due to their chemical composition have extremely low toxicity; their blue light emission can be applied to biological imaging, and their appropriate energy level (2.7 eV) allows electrons to be deposited on their surface, which allows g-CNs to be used as photosensitizers in optical therapy. Finally, g-CNs can be combined with other nanomaterials to form composite materials, which can result in new advantages not seen in either of the materials alone. In this manuscript, we thoroughly report the most recent findings regarding the synthesis of g-CNs and their respective properties. We report the advantages of g-CNs conferred by their unique properties and their advantages for application in current biology and medicines.

Rodlike AgI/Ag2Mo2O7 Heterojunctions with Enhanced Visible-Light-Driven Photocatalytic Activity

Novel AgI/Ag2Mo2O7 heterojunctions were prepared by reacting Ag2Mo2O7 microrods with an aqueous KI solution at room temperature. The composite materials, compared with neat AgI and Ag2Mo2O7, showed much higher activities in the photocatalytic degradation of aqueous rhodamine B, methyl orange, tetracycline hydrochloride, and levofloxacin solutions under visible-light irradiation. The structures, morphologies, and other physicochemical properties of AgI, Ag2Mo2O7, and AgI/Ag2Mo2O7 composites were studied via various characterization techniques. The active species involved in the photocatalytic process were examined via radical-capturing experiments and electron spin resonance. Superoxide anion radicals (•O2 -) and photogenerated holes (h+) were found to be the main active species. Photocatalytic mechanisms were proposed and reasons for the enhanced photocatalytic activity were explained.

Light-driven ultrasensitive self-powered cytosensing of circulating tumor cells via integration of biofuel cells and a photoelectrochemical strategy

Herein, a light-driven, membrane-less and mediator-less self-powered cytosensing platform via integration of biofuel cells (BFCs) and a photoelectrochemical strategy was developed for ultrasensitive detection of circulating tumor cells (CTCs). To construct cytosensors, an elaborately designed SH-Sgc8c aptamer/AuNP/g-C₃N₄ photoelectrode was used as an alternative anode for glucose oxidation, avoiding the introduction of anodic enzymes. Initially, glucose could favorably reach the photoanode surface and be easily oxidized by the photogenerated holes, while the photogenerated electrons would transfer to the biocathode and achieve biocatalytic reduction of O₂, leading to a high E^OCV. However, in the presence of CTCs, they could preferentially interact with the Sgc8c aptamer via specific recognition, and then complexes with large steric hindrance were immobilized on the photoanode surface, which could greatly affect the electron transfer between glucose and the photoanode surface. In this case, the E^OCV decreased sharply. Encouragingly, this self-powered cytosensor exhibited an ultrasensitive response to the target CTCs in a wide concentration range from 20 to 2 × 10⁵ cells mL^-1 with a low detection limit of 10 cells mL^-1 (S/N = 3), being superior to those of the reported methods. Moreover, this as-proposed self-powered cytosensor integrated with a photoelectrochemical strategy possessed unique advantages of not requiring an external power source, being anodic enzyme-free, having a simple construction process, facile miniaturization, and high selectivity and sensitivity, providing a promising and powerful tool for fundamental biochemical research and clinical diagnosis.

Recent developments of photoelectrochemical biosensors for food analysis

Recent developments of photoelectrochemical biosensors for food analysis are summarized and the future prospects in this field are discussed.

In situ sulfur-doped graphitic carbon nitride nanosheets with enhanced electrogenerated chemiluminescence used for sensitive and selective sensing of l-cysteine

In this study, in situ sulfur-doped carbon nitride nanosheets (S-g-C₃N₄ NSs) are used for the sensitive and selective sensing of l-cysteine (l-Cys) based on the competitive coordination chemistry of Cu²⁺ between l-Cys and S-g-C₃N₄ NSs.